Search

Press Categories
Press Categories
Distributor Regions
Distributor Regions
Event Type
Event Type

Results

Helsinki - 5th of November, 2021 - MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in…

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172…

Did you know that more than 60% of cancer patients will receive radiation therapy, a local treatment that is based on the use of ionizing radiation to cause damage to tumor cells and prevent the growth and proliferation, at some point in the treatment? The quality and atmosphere of radiotherapy…

The cancer rates in Spain are rather unsettling. In 2020 alone, there were well over 282,000 new cancer cases and over 113,000 cancer deaths. Currently, the five most common types of cancer that have devastated the Spanish population overall are:  (more…)

Machine learning has become vital to the modern world, turning data into real, actionable insights. In radiotherapy, there has been a continuous increase in patient-specific needs met with the help of artificial intelligence, from quality personalized treatment to medical imaging.  In the machine learning field, there are two main types…

According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…

According to the Mayo Clinic, more than half of all people with cancer receive radiation therapy as part of their cancer treatment. Although radiotherapy has become a more increasingly common aspect of the cancer treatment process, there are still potential challenges that oncology professionals face in the radiotherapy treatment process.…

1 in 2 people will develop some form of cancer during their lifetime. More than 14 million new cases of cancer are diagnosed each year. Radiotherapy provides a practical solution to combat this problem. Since 1985, radiotherapy has been changing the lives of cancer patients worldwide. Radiotherapy has the potential to…

HELSINKI, Finland - January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+).  In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient…

Dr. Giuseppe Sasso is a Radiation Oncologist with extensive experience in the field, who has been using MVision AI for more than a year already, as an individual customer. He graduated from University of Naples where he also finished residency training 25 years ago. Since then, he has treated patients…

SABR radiotherapy, a cutting-edge technique used to deliver highly focused doses of radiation to a very small area of the body, is revolutionising cancer treatment NHS England is already requiring radiotherapy clinics to provide SABR radiotherapy for cancer patients across - England, and this technique is practiced by many centres…

During the webinar, Jarkko discussed the critical role that guidelines and standards play in ensuring the safety and effectiveness of radiotherapy treatments. He shared insights on how MVision AI’s Guideline Based Segmentation solution drives and automates compliance with these guidelines and improves the overall quality of care for patients. …

The interview of Jarkko Niemelä, CEO, and Co-founder of MVision AI, for IntelligentHealth.tech magazine. October 2023. What specific challenges does Contour+ address in the field of radiotherapy, and how does its AI-powered automation contribute to overcoming these challenges? The largest challenge in cancer radiotherapy is the shortage of experts, including…

The rate of new cases of cancer yearly is 442.4 per 100,000 amongst men and women per year (based on 2013–2017 cases). The most common cancers cases in 2020 were breast cancer, lung and bronchus cancer, prostate cancer, and colon and rectum cancer. Of the patients treated with cancer in…

Elsevier Health recently published a “Clinician of the future” report, based on the results of an online survey which gathered the perspectives of more than 2600 clinicians from 116 countries. They expressed their opinions on the future of healthcare, the opportunities and challenges they are facing in their roles. Perspectives…

Helsinki – September 6, 2021 – MVision AI, the software service provider for radiotherapy treatment planning, announces a new distribution partnership with SERES Medical, the leading Turkish medical equipment provider.  (more…)

Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a dose of radiation to a tumor. SBRT aims to employ the highest possible dose of radiation to kill cancer while minimizing damage to surrounding tissues…

Background Worldwide, more than 1 400 000 men were diagnosed with prostate cancer in 2020, and it is estimated that one third will need radiotherapy during their treatment. (more…)

We are happy to announce the publication of our first peer-reviewed paper. The retrospective multicenter study proves that using a general deep learning-based automated segmentation tool for CT images indeed saves time and improves consistency. The abstract of A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation…

The year has been an exceptional one, to say the least. It has also been a year of new growth for us at MVision AI. From successfully closing our second funding round to doubling the number of colleagues and usage volumes, we wrap up the year with gratitude. But before,…

No more posts to show

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI